Prediction of Overall Survival in Resectable Intrahepatic Cholangiocarcinoma: ISICC -Applied Prediction Model.
Mengxin Tian,Weiren Liu,Chenyang Tao,Zheng Tang,Yufu Zhou,Shushu Song,Lei Jin,Han Wang,Xifei Jiang,Peiyun Zhou,Yuan Fang,Weifeng Qu,Zhenbin Ding,Yuanfei Peng,Xiutao Fu,Shuangjian Qiu,Jian Zhou,Jia Fan,Yinghong Shi
DOI: https://doi.org/10.1111/cas.14315
IF: 5.7
2020-01-01
Cancer Science
Abstract:Intrahepatic cholangiocarcinoma (ICC) remains a highly heterogeneous disease with poor prognosis. Tumor-infiltrating lymphocytes were predictive in various cancers, but their prognostic value in ICC is less clear. A total of 168 ICC patients who had received liver resection were enrolled and assigned to the derivation cohort. Sixteen immune markers in tumor and peritumor regions were examined by immunohistochemistry. A least absolute shrinkage and selection operator model was used to identify prognostic markers and to establish an immune signature for ICC (ISICC ). An ISICC -applied prediction model was built and validated in another independent dataset. Five immune features, including CD3peritumor (P) , CD57P , CD45RAP , CD66bintratumoral (T) and PD-L1P , were identified and integrated into an individualized ISICC for each patient. Seven prognostic predictors, including total bilirubin, tumor numbers, CEA, CA19-9, GGT, HBsAg and ISICC , were integrated into the final model. The C-index of the ISICC -applied prediction model was 0.719 (95% CI, 0.660-0.777) in the derivation cohort and 0.667 (95% CI, 0.581-0.732) in the validation cohort. Compared with the conventional staging systems, the new model presented better homogeneity and a lower Akaike information criteria value in ICC. The ISICC -applied prediction model may provide a better prediction performance for the overall survival of patients with resectable ICC in clinical practice.